PATENT CLAIM ANALYSIS

Application Number: 15752144
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "047000"]

Abstract:
A class of polycyclic compounds of general formula (II), of general formula (II′), or of general formula (II″), wherein Base 1 , Base 2 , Y, Y a , X a , X a1 , X b , X b1 , X c , X c1 , X d , X d1 , R 1 , R 1a , R 2 , R 2a , R 3a , R 4 , R 4a , R 5 , R 6 , R 6a , R 7 , R 7a , R 8 , and R 8a  are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.

Claim (Index 7):
A method of inducing a STING-dependent type I interferon production in a subject, said method comprising:\n (a) administering a therapeutically effective amount of a pharmaceutical composition according to  claim 3  to the subject.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 88.0
- Lexical Diversity: 2.1194
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15586634', '15368921', '15234182', '15315458', '15543007']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7771597519564226
- 35 USC 102 Novelty (BERT): 0.5239589591826315
- Combined Prediction Score: 0.7518396726790435
- Mean Citation Score: 311.508158
- Max Citation Score: 339.67236
- Similarity Product: 255.9219002162361

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test